课题基金 / 基金详情

Dimorphic growth and resting structure development in plant pathogenic verticillium species

Dimorphic growth and resting structure development in plant pathogenic verticillium species
植物致病黄萎病菌的二态性生长和休眠结构发育
批准号:
216879-2006
负责人:
Dobinson, Katherine
金额:
$1.27万
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2008
资助国家:
加拿大
项目状态:
已结题
起止时间:
2008-01-01 至 2009-12-31

项目摘要

项目成果

Dobinson, Katherine的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Verticillium dahliae, V. albo-atrum, and V. longisporum are soilborne fungi that cause vascular wilt disease in a variety of annual crops and perennials that are grown commercially in Canada and worldwide, including tomato, potato, oilseed rape, and other brassica crops.  The soil habitat of these pathogens, their inaccessibility during infection, and their ability to survive for many years in the soil, pose formidable challenges to disease control.  Few verticillium wilt-resistant cultivars are available, and chemical fumigants, which reduce levels of V. dahliae in the soil, are environmentally harmful, and destroy beneficial soil microorganisms.  Given the present and potential economic impact of the pathogen, new approaches to disease control must be considered.    One approach with much potential for disease control is to specifically target, and interfere with, the molecular processes which are critical for the growth of Verticillum in the plant, and/or its survival in the soil.  The proposed research program will focus on molecular and genetic studies of: 1) the development of the long-lived resting structures, microsclerotia or melanized mycelia, which are produced in dying plant tissues, and provide the primary source of disease inoculum, and 2) dimorphic growth (production of both yeast-like spores and mycelia), which occurs in liquid culture, and in the plant vascular system during infection.  Previous studies have shown that V. dahliae carries a gene that encodes a hydrophobin protein which is required for microsclerotia production.  The same gene has been identified in V. albo-atrum, which does not produce microsclerotia; the role of this gene in V. albo-atrum is therefore unknown.  A comparison of expression in V. albo-atrum and V. dahliae of these genes, and their respective proteins, will be carried out using reporter genes, mutational, and biochemical analysis.  In addition, DNA microarray analyses will be used to identify additional genes that are highly expressed during resting structure development and/or dimorphic growth.  Such genes will be candidates for further characterization.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterization of the molecular pathways that direct development and pathogenicity in the vascular wilt fungus Verticillium dahliae
  • 批准号:
    216879-2012
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $1.82万
  • 财政年份:
    2014
  • 负责人:
    Dobinson, Katherine
  • 依托单位:
Characterization of the molecular pathways that direct development and pathogenicity in the vascular wilt fungus Verticillium dahliae
  • 批准号:
    216879-2012
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $1.82万
  • 财政年份:
    2013
  • 负责人:
    Dobinson, Katherine
  • 依托单位:
Characterization of the molecular pathways that direct development and pathogenicity in the vascular wilt fungus Verticillium dahliae
  • 批准号:
    216879-2012
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $1.82万
  • 财政年份:
    2012
  • 负责人:
    Dobinson, Katherine
  • 依托单位:
Dimorphic growth and resting structure development in plant pathogenic verticillium species
  • 批准号:
    216879-2006
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $1.27万
  • 财政年份:
    2010
  • 负责人:
    Dobinson, Katherine
  • 依托单位:
国内基金
海外基金
基于FP-Growth关联分析算法的重症患者抗菌药物精准决策模型的构建和实证研究
  • 批准号:
    2024Y9049
  • 项目类别:
    省市级项目
  • 资助金额:
    100.0万元
  • 批准年份:
    2024
  • 负责人:
    阮君山
  • 依托单位:
含Re、Ru先进镍基单晶高温合金中TCP相成核—生长机理的原位动态研究
  • 批准号:
    52301178
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    夏万顺
  • 依托单位:
新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
  • 批准号:
    82370885
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    姚晨
  • 依托单位:
基于 Klotho 调控 FGF23/SGK1/NF-κB信号通路研究糖尿病肾病血管钙化机制及肾元颗粒干预作用
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2022
  • 负责人:
  • 依托单位: